Diane E. Wilfong - 10 Sep 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
SVP, Controller & CAO
Signature
/s/ Edward S. Son by Power of Attorney for Diane E. Wilfong
Issuer symbol
GILD
Transactions as of
10 Sep 2022
Transactions value $
-$9,661
Form type
4
Filing time
12 Sep 2022, 16:03:33 UTC
Previous filing
11 Aug 2022
Next filing
02 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +318 +1.13% 28.5K 10 Sep 2022 Direct F1
transaction GILD Common Stock Tax liability -$9.66K -148 -0.52% $65.28 28.3K 10 Sep 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -318 -2.35% 13.2K 10 Sep 2022 Common Stock 318 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.